Position in ADMA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,318
-$511 QoQ
Shares Held
516
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#286
of 321 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADIRONDACK TRUST CO holds $508,583 across 8 Biotechnology names. ADMA ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
375 | $233,827 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
443 | $220,051 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
2,500 | $36,425 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
188 | $7,333 | |
| 5 | PGEN |
Precigen, Inc.
|
1,000 | $5,700 | |
| 6 | ADMA |
Adma Biologics, Inc.
This page
|
516 | $4,318 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
25 | $503 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
43 | $426 |
All Filings in ADMA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,318 | 516 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,829 | 536 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $9,776 | 536 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $7,857 | 536 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $10,652 | 585 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $11,606 | 585 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $10,032 | 585 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $11,694 | 585 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $6,540 | 585 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $3,861 | 585 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $2,644 | 585 | Shares | Sole | 2024-03-29 | |
| No filing history on record for this holder in this stock. | ||||||